UPDATE: Wedbush Initiates Coverage On Achaogen On High Clinical Risk

By: via Benzinga
In a report published Tuesday, Wedbush analyst Heather Behanna initiated coverage on Achaogen Inc (NASDAQ: AKAO) with a Neutral rating ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.